問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

譚俊祥Tan, Chun-Hsiang
  • Co-Principal Investigator
  • Clinical Trial Experience (year) 7 years 9 個月

篩選

List

1Cases

2016-12-31 - 2023-12-31

Phase III

A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
  • Condition/Disease

    Prodromal Alzheimer's Disease

  • Test Drug

    Solanezumab (LY2062430)

Participate Sites
10Sites

Terminated9Sites